Switzerland to Approve FDA-Certified Medical Devices in 2025

In Q2 2025, the Federal Council will decide how and at what pace it will implement the Müller motion (20.3211), referred by parliament. This motion calls for medical devices with FDA approval to be allowed in Switzerland in the future.

This week, Swiss Medtech published its Director’s Position on the matter, advocating for Switzerland to implement the Müller motion swiftly and efficiently. Swiss Medtech believes that this move would help address supply bottlenecks, facilitate quicker access to innovative products, and stimulate economic growth by making Switzerland a more attractive destination for global MedTech companies. Additionally, it would strengthen Switzerland’s geopolitical ties with the US, while still maintaining a balanced relationship with Europe.

For an questions on the approval of FDA-certified medical devices in Switzerland, please contact us.